vs

Side-by-side financial comparison of Energy Recovery, Inc. (ERII) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $66.9M, roughly 1.1× Energy Recovery, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $6.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 8.1%).

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

ERII vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.1× larger
PBYI
$75.5M
$66.9M
ERII
Growing faster (revenue YoY)
PBYI
PBYI
+28.0% gap
PBYI
27.7%
-0.3%
ERII
More free cash flow
PBYI
PBYI
$8.0M more FCF
PBYI
$14.4M
$6.4M
ERII
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
8.1%
ERII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ERII
ERII
PBYI
PBYI
Revenue
$66.9M
$75.5M
Net Profit
$26.9M
Gross Margin
67.2%
69.3%
Operating Margin
46.8%
22.7%
Net Margin
40.2%
Revenue YoY
-0.3%
27.7%
Net Profit YoY
14.7%
EPS (diluted)
$0.49
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ERII
ERII
PBYI
PBYI
Q4 25
$66.9M
$75.5M
Q3 25
$32.0M
$54.5M
Q2 25
$28.1M
$52.4M
Q1 25
$46.0M
Q4 24
$67.1M
$59.1M
Q3 24
$38.6M
$80.5M
Q2 24
$27.2M
$47.1M
Q1 24
$12.1M
$43.8M
Net Profit
ERII
ERII
PBYI
PBYI
Q4 25
$26.9M
Q3 25
$3.9M
$8.8M
Q2 25
$2.1M
$5.9M
Q1 25
$3.0M
Q4 24
$23.5M
Q3 24
$8.5M
$20.3M
Q2 24
$-642.0K
$-4.5M
Q1 24
$-8.3M
$-4.8M
Gross Margin
ERII
ERII
PBYI
PBYI
Q4 25
67.2%
69.3%
Q3 25
64.2%
77.7%
Q2 25
64.0%
76.5%
Q1 25
77.1%
Q4 24
70.2%
76.4%
Q3 24
65.1%
63.9%
Q2 24
64.6%
77.4%
Q1 24
59.0%
75.5%
Operating Margin
ERII
ERII
PBYI
PBYI
Q4 25
46.8%
22.7%
Q3 25
11.4%
17.6%
Q2 25
5.3%
12.7%
Q1 25
8.7%
Q4 24
38.2%
22.6%
Q3 24
18.3%
27.4%
Q2 24
-7.4%
-4.6%
Q1 24
-90.4%
-5.3%
Net Margin
ERII
ERII
PBYI
PBYI
Q4 25
40.2%
Q3 25
12.1%
16.2%
Q2 25
7.3%
11.2%
Q1 25
6.5%
Q4 24
35.0%
Q3 24
22.0%
25.2%
Q2 24
-2.4%
-9.6%
Q1 24
-68.3%
-11.0%
EPS (diluted)
ERII
ERII
PBYI
PBYI
Q4 25
$0.49
$0.26
Q3 25
$0.07
$0.17
Q2 25
$0.04
$0.12
Q1 25
$0.06
Q4 24
$0.40
$0.40
Q3 24
$0.15
$0.41
Q2 24
$-0.01
$-0.09
Q1 24
$-0.14
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ERII
ERII
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$75.2M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$206.2M
$130.3M
Total Assets
$231.5M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ERII
ERII
PBYI
PBYI
Q4 25
$75.2M
$97.5M
Q3 25
$70.4M
$94.4M
Q2 25
$79.5M
$96.0M
Q1 25
$93.2M
Q4 24
$78.0M
$101.0M
Q3 24
$118.6M
$96.7M
Q2 24
$101.0M
$96.8M
Q1 24
$117.4M
$107.2M
Total Debt
ERII
ERII
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
ERII
ERII
PBYI
PBYI
Q4 25
$206.2M
$130.3M
Q3 25
$180.8M
$115.3M
Q2 25
$185.2M
$104.7M
Q1 25
$97.1M
Q4 24
$210.0M
$92.1M
Q3 24
$233.9M
$71.1M
Q2 24
$218.5M
$48.5M
Q1 24
$216.0M
$51.0M
Total Assets
ERII
ERII
PBYI
PBYI
Q4 25
$231.5M
$216.3M
Q3 25
$209.6M
$202.9M
Q2 25
$212.3M
$194.9M
Q1 25
$196.2M
Q4 24
$242.8M
$213.3M
Q3 24
$262.7M
$220.7M
Q2 24
$249.0M
$205.0M
Q1 24
$244.3M
$214.1M
Debt / Equity
ERII
ERII
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ERII
ERII
PBYI
PBYI
Operating Cash FlowLast quarter
$7.1M
$14.4M
Free Cash FlowOCF − Capex
$6.4M
$14.4M
FCF MarginFCF / Revenue
9.6%
19.1%
Capex IntensityCapex / Revenue
1.0%
0.0%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$15.8M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ERII
ERII
PBYI
PBYI
Q4 25
$7.1M
$14.4M
Q3 25
$-3.1M
$9.7M
Q2 25
$4.1M
$14.1M
Q1 25
$3.6M
Q4 24
$9.0M
$15.6M
Q3 24
$-3.0M
$11.0M
Q2 24
$8.1M
$1.0M
Q1 24
$6.5M
$11.2M
Free Cash Flow
ERII
ERII
PBYI
PBYI
Q4 25
$6.4M
$14.4M
Q3 25
$-3.5M
$9.7M
Q2 25
$4.0M
$14.1M
Q1 25
$3.6M
Q4 24
$8.9M
$15.6M
Q3 24
$-3.2M
$11.0M
Q2 24
$7.9M
$1.0M
Q1 24
$5.7M
FCF Margin
ERII
ERII
PBYI
PBYI
Q4 25
9.6%
19.1%
Q3 25
-10.9%
17.7%
Q2 25
14.3%
26.8%
Q1 25
7.7%
Q4 24
13.2%
26.4%
Q3 24
-8.2%
13.7%
Q2 24
28.9%
2.1%
Q1 24
46.9%
Capex Intensity
ERII
ERII
PBYI
PBYI
Q4 25
1.0%
0.0%
Q3 25
1.1%
0.0%
Q2 25
0.5%
0.0%
Q1 25
0.1%
Q4 24
0.2%
0.0%
Q3 24
0.4%
0.0%
Q2 24
0.7%
0.0%
Q1 24
6.8%
0.0%
Cash Conversion
ERII
ERII
PBYI
PBYI
Q4 25
0.26×
Q3 25
-0.81×
1.10×
Q2 25
2.02×
2.41×
Q1 25
1.21×
Q4 24
0.38×
Q3 24
-0.35×
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons